{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:41:35Z","timestamp":1792424495429,"version":"4.5.0"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejca.2026.116230","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T16:25:57Z","timestamp":1768235157000},"page":"116230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Comprehensive review of pregnancy associated breast cancer: Clinical features, molecular characteristics and novel therapies"],"prefix":"10.1016","volume":"235","author":[{"given":"Alessandra","family":"Spata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana M.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5943-6066","authenticated-orcid":false,"given":"Paolo","family":"Vigneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1374-1831","authenticated-orcid":false,"given":"Alberto","family":"Zambelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8811-4085","authenticated-orcid":false,"given":"Jean","family":"Zeghondy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chayma","family":"Bousrih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8567-9627","authenticated-orcid":false,"given":"Thomas","family":"Grinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Viansone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre J.","family":"Vivanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u00ebl","family":"Grynberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4839-6038","authenticated-orcid":false,"given":"Bruno Achutti","family":"Duso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9184-7199","authenticated-orcid":false,"given":"Barbara","family":"Pistilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7906-0991","authenticated-orcid":false,"given":"Elie","family":"Rassy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2026.116230_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.105553","article-title":"The rising tides of cancers among young adults","volume":"10","author":"Andr\u00e9","year":"2025","journal-title":"ESMO Open"},{"key":"10.1016\/j.ejca.2026.116230_bib2","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2026.116230_bib3","unstructured":"Statistics | Eurostat n.d. \u3008https:\/\/ec.europa.eu\/eurostat\/databrowser\/view\/tps00017\/default\/bar?lang=en&category=t_demo.t_demo_fer\u3009 (accessed July 17, 2025)."},{"key":"10.1016\/j.ejca.2026.116230_bib4","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa2212856","article-title":"Interrupting endocrine therapy to attempt pregnancy after breast cancer","volume":"388","author":"Partridge","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2026.116230_bib5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1089\/jwh.2018.6962","article-title":"Pregnancy-associated cancer: a U.S. population-based study","volume":"28","author":"Cottreau","year":"2019","journal-title":"J Women\u2019s Health"},{"key":"10.1016\/j.ejca.2026.116230_bib6","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/aogs.14677","article-title":"Risk factors for the increasing incidence of pregnancy-associated cancer in Sweden - a population-based study","volume":"103","author":"Lundberg","year":"2024","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejca.2026.116230_bib7","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.mayocpiqo.2024.02.002","article-title":"Pregnancy-associated cancer: a systematic review and meta-analysis","volume":"8","author":"Walters","year":"2024","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"10.1016\/j.ejca.2026.116230_bib8","unstructured":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries n.d. \u3008https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/epdf\/10.3322\/caac.21834\u3009 (accessed April 28, 2025)."},{"key":"10.1016\/j.ejca.2026.116230_bib9","doi-asserted-by":"crossref","first-page":"e1027","DOI":"10.1016\/S2214-109X(20)30215-1","article-title":"Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study","volume":"8","author":"Heer","year":"2020","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ejca.2026.116230_bib10","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1470-2045(21)00183-2","article-title":"The definition of pregnancy-associated breast cancer is outdated and should no longer be used","volume":"22","author":"Amant","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2026.116230_bib11","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/AOG.0b013e3182a057a2","article-title":"Incidence of pregnancy-associated cancer in Denmark, 1977\u20132006","volume":"122","author":"Eibye","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejca.2026.116230_bib12","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/tbj.12007","article-title":"Incidence, risk factors, and obstetrical outcomes of women with breast cancer in pregnancy","volume":"18","author":"Abenhaim","year":"2012","journal-title":"Breast J"},{"key":"10.1016\/j.ejca.2026.116230_bib13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/cncr.21610","article-title":"Breast carcinoma during pregnancy. International recommendations from an expert meeting","volume":"106","author":"Loibl","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2026.116230_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrc1839","article-title":"Pregnancy-associated breast cancer and metastasis","volume":"6","author":"Schedin","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejca.2026.116230_bib15","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/biology12030408","article-title":"Breast carcinogenesis during pregnancy: molecular mechanisms, maternal and fetal adverse outcomes","volume":"12","author":"Margioula-Siarkou","year":"2023","journal-title":"Biology"},{"key":"10.1016\/j.ejca.2026.116230_bib16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.diii.2013.12.021","article-title":"A single-institution study of 117 pregnancy-associated breast cancers (PABC): presentation, imaging, clinicopathological data and outcome","volume":"95","author":"Langer","year":"2014","journal-title":"Diagn Inter Imaging"},{"key":"10.1016\/j.ejca.2026.116230_bib17","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.breast.2012.05.002","article-title":"Pregnancy-associated breast cancers: do they differ from other breast cancers in young women?","volume":"21","author":"Genin","year":"2012","journal-title":"Breast"},{"key":"10.1016\/j.ejca.2026.116230_bib18","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1186\/s12885-025-14091-2","article-title":"A systematic review and meta-analysis of pregnancy-associated breast cancer incidence rate","volume":"25","author":"Akhlaqi","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2026.116230_bib19","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3390\/diagnostics13040604","article-title":"Pregnancy-associated breast cancer: a diagnostic and therapeutic challenge","volume":"13","author":"Galati","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.ejca.2026.116230_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejogrb.2009.06.030","article-title":"Breast cancer during pregnancy","volume":"147","author":"Vinatier","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejca.2026.116230_bib21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1053\/j.seminoncol.2009.03.001","article-title":"Breast cancer before age 40 years","volume":"36","author":"Anders","year":"2009","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ejca.2026.116230_bib22","doi-asserted-by":"crossref","DOI":"10.1200\/OP-24-00867","article-title":"Pregnancy-associated breast cancer: key concepts for optimizing diagnosis and treatment","author":"Kesireddy","year":"2025","journal-title":"JCO Oncol Pr"},{"key":"10.1016\/j.ejca.2026.116230_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13167-018-0129-7","article-title":"Pregnancy-associated breast cancer: the risky status quo and new concepts of predictive medicine","volume":"9","author":"Polivka","year":"2018","journal-title":"EPMA J"},{"key":"10.1016\/j.ejca.2026.116230_bib24","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.annonc.2023.08.001","article-title":"ESMO expert consensus statements on the management of breast cancer during pregnancy (PrBC)","volume":"34","author":"Loibl","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2026.116230_bib25","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.3390\/cancers12061356","article-title":"Frequency of pregnancy-associated cancer: a systematic review of population-based studies","volume":"12","author":"Dalmartello","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2026.116230_bib26","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jamaoncol.2023.0339","article-title":"Long-term mortality in individuals diagnosed with cancer during pregnancy or postpartum","volume":"9","author":"Cairncross","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejca.2026.116230_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11912-020-0862-7","article-title":"Pregnancy and Cancer: the INCIP project","volume":"22","author":"Maggen","year":"2020","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.ejca.2026.116230_bib28","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1186\/s12885-020-07248-8","article-title":"Prognosis of pregnancy-associated breast cancer: a meta-analysis","volume":"20","author":"Shao","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2026.116230_bib29","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.3390\/ijms23073883","article-title":"The mammary gland: basic structure and molecular signaling during development","volume":"23","author":"Biswas","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejca.2026.116230_bib30","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.molmed.2019.06.003","article-title":"Pregnancy and breast cancer: pathways to understand risk and prevention","volume":"25","author":"Slepicka","year":"2019","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ejca.2026.116230_bib31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.semcdb.2020.09.014","article-title":"The molecular basis of mammary gland development and epithelial differentiation","volume":"114","author":"Slepicka","year":"2021","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.ejca.2026.116230_bib32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/bcr2723","article-title":"Key signaling nodes in mammary gland development and cancer: \u03b2-catenin","volume":"12","author":"Incassati","year":"2010","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ejca.2026.116230_bib33","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/joim.12747","article-title":"The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence","volume":"283","author":"Troisi","year":"2018","journal-title":"J Intern Med"},{"key":"10.1016\/j.ejca.2026.116230_bib34","doi-asserted-by":"crossref","DOI":"10.1186\/bcr3594","article-title":"Pregnancy-associated breast cancers are driven by differences in adipose stromal cells present during lactation","volume":"16","author":"McCready","year":"2014","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ejca.2026.116230_bib35","article-title":"The immune environment of the mammary gland fluctuates during post-lactational regression and correlates with tumour growth rate","volume":"149","author":"Hitchcock","year":"2022","journal-title":"Dev Camb Engl"},{"key":"10.1016\/j.ejca.2026.116230_bib36","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1074\/jbc.273.13.7709","article-title":"Prolactin receptor regulates Stat5 tyrosine phosphorylation and nuclear translocation by two separate pathways","volume":"273","author":"Ali","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2026.116230_bib37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrm3775","article-title":"Organization and execution of the epithelial polarity programme","volume":"15","author":"Rodriguez-Boulan","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ejca.2026.116230_bib38","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.scr.2015.08.001","article-title":"Prolactin\/Jak2 directs apical\/basal polarization and luminal linage maturation of mammary epithelial cells through regulation of the Erk1\/2 pathway","volume":"15","author":"Liu","year":"2015","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.ejca.2026.116230_bib39","doi-asserted-by":"crossref","first-page":"21598","DOI":"10.1074\/jbc.M117.794461","article-title":"Zinc transporter 2 interacts with vacuolar ATPase and is required for polarization, vesicle acidification, and secretion in mammary epithelial cells","volume":"292","author":"Lee","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2026.116230_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11400","article-title":"Essential role for a novel population of binucleated mammary epithelial cells in lactation","volume":"7","author":"Rios","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2026.116230_bib41","first-page":"9","article-title":"Studies of postpartum mammary gland involution reveal novel pro-metastatic mechanisms","volume":"5","author":"Wallace","year":"2019","journal-title":"J Cancer Metastas Treat"},{"key":"10.1016\/j.ejca.2026.116230_bib42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s10911-024-09571-3","article-title":"Gestational breast cancer: distinctive molecular and clinico-epidemiological features","volume":"29","author":"de la Haba-Rodr\u00edguez","year":"2024","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1016\/j.ejca.2026.116230_bib43","unstructured":"Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3 | Breast Cancer Research | Full Text n.d. \u3008https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr753\u3009 (accessed July 17, 2025)."},{"key":"10.1016\/j.ejca.2026.116230_bib44","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s11427-007-0077-2","article-title":"Expression and function of leptin and its receptor in mouse mammary gland","volume":"50","author":"Lin","year":"2007","journal-title":"Sci China C Life Sci"},{"key":"10.1016\/j.ejca.2026.116230_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017028","article-title":"Multiple cellular responses to serotonin contribute to epithelial homeostasis","volume":"6","author":"Pai","year":"2011","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ejca.2026.116230_bib46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/excr.2002.5666","article-title":"Leukemia inhibitory factor induces apoptosis of the mammary epithelial cells and participates in mouse mammary gland involution","volume":"282","author":"Schere-Levy","year":"2003","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.ejca.2026.116230_bib47","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.3390\/ijms19061695","article-title":"The multifaceted role of STAT3 in mammary gland involution and breast cancer","volume":"19","author":"Hughes","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejca.2026.116230_bib48","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/bcr1401","article-title":"Involution: apoptosis and tissue remodelling that convert the mammary gland from milk factory to a quiescent organ","volume":"8","author":"Watson","year":"2006","journal-title":"Breast Cancer Res BCR"},{"key":"10.1016\/j.ejca.2026.116230_bib49","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/bies.20281","article-title":"ECM degrading proteases and tissue remodelling in the mammary gland","volume":"27","author":"Green","year":"2005","journal-title":"BioEssays"},{"key":"10.1016\/j.ejca.2026.116230_bib50","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s10911-024-09568-y","article-title":"Immune cell contribution to mammary gland development","volume":"29","author":"Vickers","year":"2024","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1016\/j.ejca.2026.116230_bib51","article-title":"Parity-induced changes to mammary epithelial cells control NKT cell expansion and mammary oncogenesis","volume":"37","author":"Somasundara","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.ejca.2026.116230_bib52","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10911-010-9188-7","article-title":"Immune cell location and function during post-natal mammary gland development","volume":"15","author":"Reed","year":"2010","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1016\/j.ejca.2026.116230_bib53","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2527\/jas.2008-1333","article-title":"Immune cell regulators in mouse mammary development and involution","volume":"87","author":"Watson","year":"2009","journal-title":"J Anim Sci"},{"key":"10.1016\/j.ejca.2026.116230_bib54","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s10911-024-09568-y","article-title":"Immune cell contribution to mammary gland development","volume":"29","author":"Vickers","year":"2024","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1016\/j.ejca.2026.116230_bib55","doi-asserted-by":"crossref","first-page":"12021","DOI":"10.1073\/pnas.96.21.12021","article-title":"Progesterone receptors in the thymus are required for thymic involution during pregnancy and for normal fertility","volume":"96","author":"Tibbetts","year":"1999","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ejca.2026.116230_bib56","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1242\/dev.113.3.867","article-title":"Regulated expression and growth inhibitory effects of transforming growth factor-\u03b2 isoforms in mouse mammary gland development","volume":"113","author":"Robinson","year":"1991","journal-title":"Development"},{"key":"10.1016\/j.ejca.2026.116230_bib57","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/j.1460-2075.1993.tb05832.x","article-title":"Targeting expression of a transforming growth factor beta 1 transgene to the pregnant mammary gland inhibits alveolar development and lactation","volume":"12","author":"Jhappan","year":"1993","journal-title":"EMBO J"},{"key":"10.1016\/j.ejca.2026.116230_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.691050","article-title":"Hormone-responsive BMP signaling expands myoepithelial cell lineages and prevents alveolar precocity in mammary gland","volume":"9","author":"Shao","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.ejca.2026.116230_bib59","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1096\/fj.07-8720com","article-title":"Inactivation of VEGF in mammary gland epithelium severely compromises mammary gland development and function","volume":"21","author":"Rossiter","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.ejca.2026.116230_bib60","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.cell.2025.01.028","article-title":"Mammary intraepithelial lymphocytes promote lactogenesis and offspring fitness","volume":"188","author":"Corral","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2026.116230_bib61","unstructured":"Programme of self-reactive innate-like T cell-mediated cancer immunity | Nature n.d. \u3008https:\/\/www.nature.com\/articles\/s41586-022-04632-1\u3009 (accessed September 25, 2025)."},{"key":"10.1016\/j.ejca.2026.116230_bib62","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10911-016-9369-0","article-title":"Role of prolactin in promotion of immune cell migration into the mammary gland","volume":"22","author":"Dill","year":"2017","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1016\/j.ejca.2026.116230_bib63","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1203\/00006450-199802000-00001","article-title":"Evolution of immunologic functions of the mammary gland and the postnatal development of immunity","volume":"43","author":"Goldman","year":"1998","journal-title":"Pedia Res"},{"key":"10.1016\/j.ejca.2026.116230_bib64","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10911-014-9322-z","article-title":"Mammary gland involution as an immunotherapeutic target for postpartum breast cancer","volume":"19","author":"Fornetti","year":"2014","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1016\/j.ejca.2026.116230_bib65","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10911-014-9322-z","article-title":"Mammary gland involution as an immunotherapeutic target for postpartum breast cancer","volume":"19","author":"Fornetti","year":"2014","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1016\/j.ejca.2026.116230_bib66","unstructured":"SEMA7A semaphorin 7A (JohnMiltonHagen blood group) [Homo sapiens (human)] - Gene - NCBI n.d. \u3008https:\/\/www.ncbi.nlm.nih.gov\/gene\/8482\u3009 (accessed July 17, 2025)."},{"key":"10.1016\/j.ejca.2026.116230_bib67","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10911-015-9333-4","article-title":"New insights on COX-2 in chronic inflammation driving breast cancer growth and metastasis","volume":"20","author":"Hugo","year":"2015","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1016\/j.ejca.2026.116230_bib68","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/cr.2009.5","article-title":"TGF-\u03b2-induced epithelial to mesenchymal transition","volume":"19","author":"Xu","year":"2009","journal-title":"Cell Res"},{"key":"10.1016\/j.ejca.2026.116230_bib69","doi-asserted-by":"crossref","first-page":"734","DOI":"10.4049\/jimmunol.1800023","article-title":"Mucosal immunity in the female murine mammary gland","volume":"201","author":"Betts","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.ejca.2026.116230_bib70","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s13058-014-0427-5","article-title":"Biology of breast cancer in young women","volume":"16","author":"Azim","year":"2014","journal-title":"Breast Cancer Res BCR"},{"key":"10.1016\/j.ejca.2026.116230_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1398196","article-title":"Status of breast cancer detection in young women and potential of liquid biopsy","volume":"14","author":"Stibbards-Lyle","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejca.2026.116230_bib72","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s12905-024-03138-4","article-title":"Breast cancer and the steadily increasing maternal age: are they colliding?","volume":"24","author":"Londero","year":"2024","journal-title":"BMC Women\u2019s Health"},{"key":"10.1016\/j.ejca.2026.116230_bib73","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/cncr.31784","article-title":"Pregnancies during and after trastuzumab and\/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials","volume":"125","author":"Lambertini","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2026.116230_bib74","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.3390\/ijms19092818","article-title":"STAT3 in breast cancer onset and progression: a matter of time and context","volume":"19","author":"Segatto","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejca.2026.116230_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41523-025-00718-x","article-title":"Molecular characterization of pregnancy-associated breast cancer and insights on timing from GEICAM-EMBARCAM study","volume":"11","author":"Pe\u00f1a-Enr\u00edquez","year":"2025","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.ejca.2026.116230_bib76","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41568-024-00714-6","article-title":"Towards targeting the breast cancer immune microenvironment","volume":"24","author":"Harris","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejca.2026.116230_bib77","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12672-013-0136-z","article-title":"Genomic Signatures of pregnancy-associated breast cancer epithelia and stroma and their regulation by estrogens and progesterone","volume":"4","author":"Harvell","year":"2013","journal-title":"Horm Cancer"},{"key":"10.1016\/j.ejca.2026.116230_bib78","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0140-6736(02)09454-0","volume":"360","year":"2002","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.ejca.2026.116230_bib79","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1038\/s41467-018-06748-3","article-title":"Pregnancy duration and breast cancer risk","volume":"9","author":"Husby","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2026.116230_bib80","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10549-013-2729-1","article-title":"The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation","volume":"142","author":"Valentini","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejca.2026.116230_bib81","article-title":"416O Safety of having a subsequent pregnancy after a prior diagnosis of breast cancer during pregnancy (PrBC) in young BRCA carriers","volume":"10","author":"Perachino","year":"2025","journal-title":"ESMO Open"},{"key":"10.1016\/j.ejca.2026.116230_bib82","article-title":"Safety of pregnancy after breast cancer in young women with hormone receptor-positive disease: a systematic review and meta-analysis","volume":"8","author":"Arecco","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.ejca.2026.116230_bib83","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s10555-022-10034-6","article-title":"Oncobiology and treatment of breast cancer in young women","volume":"41","author":"Kumar","year":"2022","journal-title":"Cancer Metastas Rev"},{"key":"10.1016\/j.ejca.2026.116230_bib84","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s10911-024-09571-3","article-title":"Gestational breast cancer: distinctive molecular and clinico-epidemiological features","volume":"29","author":"de la Haba-Rodr\u00edguez","year":"2024","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1016\/j.ejca.2026.116230_bib85","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.3390\/cells11152286","article-title":"Breast cancer during pregnancy as a special type of early-onset breast cancer: analysis of the tumor immune microenvironment and risk profiles","volume":"11","author":"Sajjadi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejca.2026.116230_bib86","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2025.43.16_suppl.564","article-title":"Pregnancy-associated breast cancer: tumor infiltrating lymphocytes TILting the balance?","volume":"43","author":"Bakhuis","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2026.116230_bib87","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.breast.2015.01.009","article-title":"Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy","volume":"24","author":"Azim","year":"2015","journal-title":"Breast"},{"key":"10.1016\/j.ejca.2026.116230_bib88","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.3390\/cells11152286","article-title":"Breast cancer during pregnancy as a special type of early-onset breast cancer: analysis of the tumor immune microenvironment and risk profiles","volume":"11","author":"Sajjadi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejca.2026.116230_bib89","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10549-013-2522-1","article-title":"Stage at diagnosis and mortality in women with pregnancy-associated breast cancer (PABC)","volume":"139","author":"Johansson","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejca.2026.116230_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-020-07248-8","article-title":"Prognosis of pregnancy-associated breast cancer: a meta-analysis","volume":"20","author":"Shao","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2026.116230_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2024.103756","article-title":"6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)","volume":"76","author":"Cardoso","year":"2024","journal-title":"Breast"},{"key":"10.1016\/j.ejca.2026.116230_bib92","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(11)70363-1","article-title":"Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study","volume":"13","author":"Amant","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2026.116230_bib93","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1186\/s12885-021-08310-9","article-title":"Germline mutations in a clinic-based series of pregnancy associated breast cancer patients","volume":"21","author":"Zografos","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2026.116230_bib94","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/tbj.13510","article-title":"Pregnancy-associated breast cancer in a contemporary cohort of newly diagnosed women","volume":"26","author":"Gooch","year":"2020","journal-title":"Breast J"},{"key":"10.1016\/j.ejca.2026.116230_bib95","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10911-009-9119-7","article-title":"Pregnancy and breast cancer: when they collide","volume":"14","author":"Lyons","year":"2009","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1016\/j.ejca.2026.116230_bib96","unstructured":"Prognosis of Women With Primary Breast Cancer Diagnosed During Pregnancy: Results From an International Collaborative Study | Journal of Clinical Oncology n.d. \u3008https:\/\/ascopubs.org\/doi\/full\/10.1200\/JCO.2012.45.6335?casa_token=tQhyBpF7j0AAAAAA%3AkhJAGqouB6U1CtreD1i6FhZGnaViXLZ-tUeTBPc_iX13tQov-A8KS7STkSk0UM0oOW4VO42XaXiELxg\u3009 (accessed June 7, 2025)."},{"key":"10.1016\/j.ejca.2026.116230_bib97","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1186\/s12885-020-07248-8","article-title":"Prognosis of pregnancy-associated breast cancer: a meta-analysis","volume":"20","author":"Shao","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2026.116230_bib98","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1158\/2159-8290.CD-22-1340","article-title":"Early-stage breast cancer detection in breast milk","volume":"13","author":"Saura","year":"2023","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ejca.2026.116230_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41523-018-0077-3","article-title":"Breast cancer diagnosed during pregnancy is associated with enrichment of non-silent mutations, mismatch repair deficiency signature and mucin mutations","volume":"4","author":"Nguyen","year":"2018","journal-title":"Npj Breast Cancer"},{"key":"10.1016\/j.ejca.2026.116230_bib100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13058-015-0538-7","article-title":"RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy","volume":"17","author":"Azim","year":"2015","journal-title":"Breast Cancer Res BCR"},{"key":"10.1016\/j.ejca.2026.116230_bib101","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1038\/s41467-021-26505-3","article-title":"Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes","volume":"12","author":"Jindal","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2026.116230_bib102","doi-asserted-by":"crossref","unstructured":"Azim H.A., Broh\u00e9e S., Peccatori F.A., Desmedt C., Loi S., Lambrechts D., et al. Biology of breast cancer during pregnancy using genomic profiling 2014. https:\/\/doi.org\/10.1530\/ERC-14-0111.","DOI":"10.1530\/ERC-14-0111"},{"key":"10.1016\/j.ejca.2026.116230_bib103","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1158\/1940-6207.CAPR-09-0069","article-title":"Gene expression patterns in the human breast after pregnancy","volume":"3","author":"Asztalos","year":"2010","journal-title":"Cancer Prev Res (Phila Pa)"},{"key":"10.1016\/j.ejca.2026.116230_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-022-05110-2","article-title":"Glycosylated modification of MUC1 maybe a new target to promote drug sensitivity and efficacy for breast cancer chemotherapy","volume":"13","author":"Xi","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ejca.2026.116230_bib105","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41523-025-00758-3","article-title":"Effects of pregnancy on breast cancer immunology: immune biomarker and TIL quantification","volume":"11","author":"Galas","year":"2025","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.ejca.2026.116230_bib106","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13058-025-02097-4","article-title":"Characterization of the tumor immune microenvironment in pregnancy-associated breast cancer through multiplex immunohistochemistry and transcriptome analyses","volume":"27","author":"Chen","year":"2025","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ejca.2026.116230_bib107","unstructured":"NCCN Clinical Practice Guidelines in Oncology - Breast Cancer - Version 2025 n.d."},{"key":"10.1016\/j.ejca.2026.116230_bib108","doi-asserted-by":"crossref","DOI":"10.1200\/OP-24-00453","article-title":"Multidisciplinary management of pregnancy-associated breast cancer","author":"Roesch","year":"2025","journal-title":"JCO Oncol Pr"},{"key":"10.1016\/j.ejca.2026.116230_bib109","doi-asserted-by":"crossref","first-page":"vi160","DOI":"10.1093\/annonc\/mdt199","article-title":"Cancer, pregnancy and fertility: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2020","volume":"24","author":"Peccatori","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2026.116230_bib110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.annonc.2023.11.016","article-title":"Early breast cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"35","author":"Loibl","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2026.116230_bib111","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1186\/s12885-021-08162-3","article-title":"Trastuzumab administration during pregnancy: an update","volume":"21","author":"Andrikopoulou","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2026.116230_bib112","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10549-012-2368-y","article-title":"Trastuzumab administration during pregnancy: a systematic review and meta-analysis","volume":"137","author":"Zagouri","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejca.2026.116230_bib113","unstructured":"Drugs and Lactation Database (LactMed\u00ae). National Institute of Child Health and Human Development; 2006."},{"key":"10.1016\/j.ejca.2026.116230_bib114","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00281-025-01051-y","article-title":"Immune checkpoint for pregnancy","volume":"47","author":"Hu","year":"2025","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.ejca.2026.116230_bib115","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.5625","article-title":"Immune checkpoint inhibitor use during pregnancy and outcomes in pregnant individuals and newborns","volume":"7","author":"Gougis","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejca.2026.116230_bib116","doi-asserted-by":"crossref","first-page":"e550","DOI":"10.1016\/S1470-2045(21)00525-8","article-title":"Immunotherapy for cancer treatment during pregnancy","volume":"22","author":"Borgers","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2026.116230_bib117","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/cancers15010173","article-title":"Immune checkpoint inhibitors and pregnancy: analysis of the VigiBase\u00ae spontaneous reporting system","volume":"15","author":"Noseda","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2026.116230_bib118","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.repbre.2023.10.003","article-title":"A regression approach for assessing large molecular drug concentration in breast milk","volume":"3","author":"Stratigakis","year":"2023","journal-title":"Reprod Breed"},{"key":"10.1016\/j.ejca.2026.116230_bib119","series-title":"Drugs Lact. Database Lact","author":"Pembrolizumab","year":"2006"},{"key":"10.1016\/j.ejca.2026.116230_bib120","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1530\/REP-13-0588","article-title":"PARP1 during embryo implantation and its upregulation by oestradiol in mice","volume":"147","author":"Joshi","year":"2014","journal-title":"Reproduction"},{"key":"10.1016\/j.ejca.2026.116230_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104696","article-title":"PARP inhibitors during conception and pregnancy in breast cancer","volume":"210","author":"Zagouri","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejca.2026.116230_bib122","series-title":"Drugs Lact. Database lact","author":"Olaparib","year":"2006"},{"key":"10.1016\/j.ejca.2026.116230_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102113","article-title":"Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations","volume":"62","author":"D\u2019Arienzo","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.ejca.2026.116230_bib124","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1177\/030089161209800627","article-title":"Irinotecan during pregnancy in metastatic colon cancer","volume":"98","author":"Cirillo","year":"2012","journal-title":"Tumor J"},{"key":"10.1016\/j.ejca.2026.116230_bib125","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/diagnostics14050559","article-title":"Diagnostic, management, and neonatal outcomes of colorectal cancer during pregnancy: two case reports, systematic review of literature and metanalysis","volume":"14","author":"Galante","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.ejca.2026.116230_bib126","unstructured":"Irinotecan Monograph for Professionals - Drugs.com n.d. \u3008https:\/\/www.drugs.com\/monograph\/irinotecan.html\u3009 (accessed July 1, 2025)."},{"key":"10.1016\/j.ejca.2026.116230_bib127","series-title":"Drugs Lact. Database Lact. Internet","author":"Trastuzumab Deruxtecan","year":"2023"},{"key":"10.1016\/j.ejca.2026.116230_bib128","series-title":"Drugs Lact. Database Lact. Internet","author":"Govitecan","year":"2023"},{"key":"10.1016\/j.ejca.2026.116230_bib129","unstructured":"Ibrance, Product Monograph. \u3008https:\/\/pdf.hres.ca\/dpd_pm\/00045824.PDF\u3009 n.d."},{"key":"10.1016\/j.ejca.2026.116230_bib130","unstructured":"Kisqali, Product Monograph. \u3008https:\/\/pdf.hres.ca\/dpd_pm\/00044564.PDF\u3009 n.d."},{"key":"10.1016\/j.ejca.2026.116230_bib131","unstructured":"Verzenio, Product Monograph, \u3008https:\/\/pi.lilly.com\/ca\/verzenio-ca-pm.pdf\u3009 n.d."},{"key":"10.1016\/j.ejca.2026.116230_bib132","series-title":"Bethesda (MD)","article-title":"Drugs Lact. Database Lact","author":"Ribociclib","year":"2006"},{"key":"10.1016\/j.ejca.2026.116230_bib133","series-title":"Bethesda (MD)","article-title":"Drugs Lact. Database Lact","author":"Abemaciclib","year":"2006"},{"key":"10.1016\/j.ejca.2026.116230_bib134","series-title":"Bethesda (MD)","article-title":"Drugs Lact. Database Lact","author":"Palbociclib","year":"2006"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926000109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926000109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T09:36:02Z","timestamp":1770716162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926000109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":134,"alternative-id":["S0959804926000109"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116230","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive review of pregnancy associated breast cancer: Clinical features, molecular characteristics and novel therapies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116230","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116230"}}